StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Manas Jaiswal

BUYRainbow Childrens Medicare Limited
Rainbow Childrens Medicare share price target & all analyst calls

byManas JaiswalHorizon: NA (inferred Intraday)4 Aug 2026, 7:32 am ISTvia CNBC Awaaz.

Entry₹1,540.1Inferred
Target₹1,570
Total upside +1.94% (call closed)
Stop loss₹1,520-1.31% risk
Exit₹1,5704 Aug 2026, 12:11 pm
Target hit+1.94%0.00%upside left
Follow Manas Jaiswal for new calls(11% target hit, 148 closed calls)Get alertsWatch RAINBOW for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Aug 2026
6 supporting1 neutral0 opposing
Supports the BUY call (6)

Rainbow Children's Medicare Ltd announced its financial results for the quarter ended June 30, 2026, reporting a robust performance with revenue growth of approximately 33% YoY. The company also highl

BSE · Company Update·30 Jul · 4d ago

(opens in new tab)

Rainbow Children's Medicare Q1 profit rises 13% as revenue jumps 33%

NewsCnbc-Tv18·30 Jul · 4d ago

(opens in new tab)

Rainbow Children's Medicare Ltd is acquiring a 64% partnership interest in Super Prime Medical Care LLP for ₹19.84 Cr, which operates a 70-bed children's hospital in Nellore, Andhra Pradesh. This acqu

BSE · Company Update·29 Jul · 5d ago

(opens in new tab)

Rainbow Childrens Medicare Limited will acquire a 64% partnership interest in Super Prime Medical Care LLP for ₹19.84 Cr, making the LLP a subsidiary. This acquisition aims to establish a children's h

NSE · Acquisition·29 Jul · 5d ago

(opens in new tab)

Rainbow Children's Medicare Ltd is acquiring a 24% equity stake in its wholly owned subsidiary, RWCHPL, for approximately ₹90 Crore. This investment will fund the development of a new children's and w

BSE · Company Update·29 Jul · 5d ago

(opens in new tab)
Neutral / worth noting (1)

Rainbow Childrens Medicare Limited announced its un-audited financial results for the quarter ended June 30, 2026. The company reported revenue growth of ~33% YoY, driven by strong performance across

NSE · Press Release·30 Jul · 4d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Rainbow Childrens Medicare

All analyst calls on Rainbow Childrens Medicare

More from Manas Jaiswal

Every call and its outcome